Abrysvo Data In Younger Adults Could Give Pfizer An Edge Over GSK

 
• By Jessica Merrill
  
RSV
Pfizer announced positive Phase III data for its RSV vaccine Abrysvo. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anti-infective

More from Therapeutic Category